Contrast-Enhanced Three-Dimensional Pulmonary Perfusion Magnetic Resonance Imaging: Intraindividual Comparison of 1.0 M Gadobutrol and 0.5 M Gd-DTPA at Three Dose Levels

Rationale and Objectives:To compare 1.0 M gadobutrol and 0.5 M Gd-DTPA for contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging (3D MRI). Materials and Methods:Ten healthy volunteers (3 females; 7 males; median age, 27 years; age range, 18–31 years) were examined with contrast-enhanced dynamic 3D MRI with parallel acquisition technique (FLASH 3D; reconstruction algorithm: generalized autocalibrating partially parallel acquisitions; acceleration factor: 2; TE/TR/&agr;: 0.8/1.9 milliseconds/40°; FOV: 500 × 375 mm; matrix: 256 × 86; slab thickness: 180 mm; 36 partitions; voxel size: 4.4 × 2 × 5 mm3; TA: 1.48 seconds). Twenty-five consecutive data sets were acquired after intravenous injection of 0.025, 0.05, and 0.1 mmol/kg body weight of gadobutrol and Gd-DTPA. Quantitative measurements of peak signal-to-noise ratios (SNR) of both lungs were performed independently by 3 readers. Bolus transit times through the lungs were assessed from signal intensity time curves. Results:The peak SNR in the lungs was comparable between gadobutrol and Gd-DTPA at all dose levels (15.7 vs. 15.5 at 0.1 mmol/kg bw; 12.9 vs. 12.5 at 0.05 mmol/kg bw; 7.6 vs. 8.9 at 0.025 mmol/kg bw). A dose of 0.1 mmol/kg achieved the highest peak SNR compared with all other dose levels (P < 0.05). A higher peak SNR was observed in gravity dependent lung (P < 0.05). Despite different injection volumes, transit times of the contrast bolus did not differ between both agents. Conclusion:Higher concentrated gadolinium chelates offer no advantage over standard 0.5 M Gd-DTPA for contrast-enhanced 3D MRI of lung perfusion.

[1]  W. Heindel,et al.  Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol , 2002, European Radiology.

[2]  H. Shima,et al.  Effect of the rate of gadolinium injection on magnetic resonance pulmonary perfusion imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[3]  K. Suga,et al.  Regional Lung Functional Impairment in Acute Airway Obstruction and Pulmonary Embolic Dog Models Assessed With Gadolinium-Based Aerosol Ventilation and Perfusion Magnetic Resonance Imaging , 2002, Investigative radiology.

[4]  R. Slutsky,et al.  Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA. , 1985, Radiology.

[5]  B. Jonson,et al.  Pulmonary perfusion and density gradients in healthy volunteers. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  K. Suga,et al.  Perfusion Characteristics of Oleic Acid–Injured Canine Lung on Gd-DTPA–Enhanced Dynamic Magnetic Resonance Imaging , 2001, Investigative radiology.

[7]  F. Floemer,et al.  Intraindividueller Vergleich dreier Kontrastmittel (Gd-DTPA, Gd-BOPTA und Gd-BT-DO3A) mit der multiphasischen MR-Angiographie , 2003, Der Radiologe.

[8]  K. Suga,et al.  Perfusion Characteristics of Radiation-Injured Lung on Gd-DTPA-Enhanced Dynamic Magnetic Resonance Imaging , 2002, Investigative radiology.

[9]  P. Croisille,et al.  Prospective comparison of MR lung perfusion and lung scintigraphy , 1999, Journal of magnetic resonance imaging : JMRI.

[10]  A. Sorensen,et al.  Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol. , 2003, Radiology.

[11]  Michael Bock,et al.  Partially Parallel Three‐Dimensional Magnetic Resonance Imaging for the Assessment of Lung Perfusion – Initial Results , 2003, Investigative radiology.

[12]  R. Strecker,et al.  Assessment of Pulmonary Perfusion With Ultrafast Projection Magnetic Resonance Angiography in Comparison With Lung Perfusion Scintigraphy in Patients With Malignant Stenosis , 2002, Investigative radiology.

[13]  Robin M Heidemann,et al.  Generalized autocalibrating partially parallel acquisitions (GRAPPA) , 2002, Magnetic resonance in medicine.

[14]  R R Edelman,et al.  Quantitative assessment of pulmonary perfusion with dynamic contrast‐enhanced MRI , 1999, Magnetic resonance in medicine.

[15]  T. Iwasawa,et al.  Prediction of postoperative pulmonary function using perfusion magnetic resonance imaging of the lung , 2002, Journal of magnetic resonance imaging : JMRI.

[16]  J. Debatin,et al.  Intraindividual Comparison of Gadopentetate Dimeglumine, Gadobenate Dimeglumine, and Gadobutrol for Pelvic 3D Magnetic Resonance Angiography , 2003, Investigative radiology.

[17]  H. Weinmann,et al.  Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging. , 1995, European journal of radiology.

[18]  G H Glover,et al.  Lung parenchyma: magnetic susceptibility in MR imaging. , 1991, Radiology.

[19]  J. Debatin,et al.  0.5 M Gd chelate (Magnevist®) versus 1.0 M Gd chelate (Gadovist®): Dose‐independent effect on image quality of pelvic three‐dimensional MR‐angiography , 2001, Journal of magnetic resonance imaging : JMRI.

[20]  R. Edelman,et al.  Demonstration of gravity‐dependent lung perfusion with contrast‐enhanced magnetic resonance imaging , 1999, Journal of magnetic resonance imaging : JMRI.

[21]  H. Weinmann,et al.  Pharmacokinetics, Dose Proportionality, and Tolerability of Gadobutrol after Single Intravenous Injection in Healthy Volunteers , 1994, Investigative radiology.

[22]  P. Croisille,et al.  Lung perfusion demonstrated by contrast-enhanced dynamic magnetic resonance imaging. Application to unilateral lung transplantation. , 1997, Investigative radiology.

[23]  R R Edelman,et al.  Pulmonary perfusion: Qualitative assessment with dynamic contrast‐enhanced MRI using ultra‐short TE and inversion recovery turbo FLASH , 1996, Magnetic resonance in medicine.

[24]  M. Knopp,et al.  [Multiphasic MR angiography as an intra-individual comparison between the contrast agents Gd-DTPA, Gd-BOPTA, and Gd-BT-DO3A]. , 2003, Der Radiologe.